tiprankstipranks
Advertisement
Advertisement

HK:9966 Stock Latest News

Alphamab Oncology Grants 250,000 Restricted Award Shares to Key Employees
Company AnnouncementsAlphamab Oncology Grants 250,000 Restricted Award Shares to Key Employees
5d ago
9966
Alphamab Oncology Secures Waiver to Appoint Joint Company Secretary
PremiumCompany Announcements
Alphamab Oncology Secures Waiver to Appoint Joint Company Secretary
6d ago
9966
Alphamab’s KN026 Breast Cancer Trial Secures High-Profile ASCO 2026 Slot
PremiumCompany Announcements
Alphamab’s KN026 Breast Cancer Trial Secures High-Profile ASCO 2026 Slot
7d ago
9966
Alphamab Oncology Reshapes Company Secretariat, Seeks Listing Rules Waiver
PremiumCompany Announcements
Alphamab Oncology Reshapes Company Secretariat, Seeks Listing Rules Waiver
20d ago
9966
Alphamab’s KN026 Phase III Breast Cancer Trial Hits Key Efficacy Goal
PremiumCompany Announcements
Alphamab’s KN026 Phase III Breast Cancer Trial Hits Key Efficacy Goal
28d ago
9966
Alphamab Oncology Swings to Loss as R&D Spend Climbs but Cancer Pipeline Advances
PremiumCompany AnnouncementsAlphamab Oncology Swings to Loss as R&D Spend Climbs but Cancer Pipeline Advances
1M ago
9966
Alphamab Starts Phase III Trial of Next-Gen HER2 Drug in High-Risk Breast Cancer
Premium
Company Announcements
Alphamab Starts Phase III Trial of Next-Gen HER2 Drug in High-Risk Breast Cancer
1M ago
9966
Alphamab Advances JSKN016 Into Phase III for Hard-to-Treat Breast Cancer
Premium
Company Announcements
Alphamab Advances JSKN016 Into Phase III for Hard-to-Treat Breast Cancer
1M ago
9966
Alphamab Oncology Names New CFO as Capital Markets Vice President Resigns
PremiumCompany Announcements
Alphamab Oncology Names New CFO as Capital Markets Vice President Resigns
1M ago
9966
Alphamab Oncology Starts First-in-Human Trial of Novel Bispecific ADC JSKN027
PremiumCompany Announcements
Alphamab Oncology Starts First-in-Human Trial of Novel Bispecific ADC JSKN027
1M ago
9966
Alphamab Wins CDE Nod for First-in-Class Dual-Payload Cancer ADC JSKN021
PremiumCompany Announcements
Alphamab Wins CDE Nod for First-in-Class Dual-Payload Cancer ADC JSKN021
2M ago
9966
Alphamab Oncology Sets Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Alphamab Oncology Sets Board Meeting to Approve 2025 Annual Results
2M ago
9966
Alphamab Oncology Names Veteran Biologics Executive as Chief Technology Officer
PremiumCompany AnnouncementsAlphamab Oncology Names Veteran Biologics Executive as Chief Technology Officer
2M ago
9966
Alphamab Oncology’s KN035 NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
Premium
Company Announcements
Alphamab Oncology’s KN035 NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
4M ago
9966
Alphamab Wins CDE Acceptance for Phase II Trial of Novel Cervical Cancer Therapy JSKN033
Premium
Company Announcements
Alphamab Wins CDE Acceptance for Phase II Trial of Novel Cervical Cancer Therapy JSKN033
4M ago
9966
Alphamab Oncology’s JSKN003 Receives FDA Breakthrough Therapy Designation
PremiumCompany Announcements
Alphamab Oncology’s JSKN003 Receives FDA Breakthrough Therapy Designation
4M ago
9966
Alphamab Oncology Advances Revolutionary JSKN027 ADC to Clinical Stage
PremiumCompany Announcements
Alphamab Oncology Advances Revolutionary JSKN027 ADC to Clinical Stage
4M ago
9966
Alphamab Oncology Initiates HK$30 Million Share Repurchase Plan
PremiumCompany Announcements
Alphamab Oncology Initiates HK$30 Million Share Repurchase Plan
6M ago
9966
Alphamab Oncology’s JSKN003 Gains U.S. FDA Fast Track Designation
PremiumCompany Announcements
Alphamab Oncology’s JSKN003 Gains U.S. FDA Fast Track Designation
6M ago
9966
Alphamab Oncology’s JSKN003 Gains U.S. FDA Fast Track Designation
PremiumCompany AnnouncementsAlphamab Oncology’s JSKN003 Gains U.S. FDA Fast Track Designation
6M ago
9966
Alphamab Oncology Grants Award Shares to Key Personnel
Premium
Company Announcements
Alphamab Oncology Grants Award Shares to Key Personnel
6M ago
9966
Alphamab Oncology’s JSKN003 Receives Breakthrough Therapy Designation for HER2+ CRC
Premium
Company Announcements
Alphamab Oncology’s JSKN003 Receives Breakthrough Therapy Designation for HER2+ CRC
6M ago
9966

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >